| Literature DB >> 9396050 |
T W Moody1, M J Miller, A Mártinez, E Unsworth, F Cuttitta.
Abstract
The effects of adrenomedullin (ADM) on C6 glioma cells were investigated. [125I]ADM bound with high affinity (Kd = 24 nM) to a single class of sites (Bmax = 36,000/cell) in C6 cells. Specific [125I]ADM binding was inhibited with high affinity by ADM (IC50 value of 10 nM) but not ADM(22-52) or pro-adrenomedullin N-terminal 20 peptide (PAMP). By RT-PCR, ADM receptors were detected in C6 cells. ADM elevated cAMP (ED50 value of 10 nM) whereas PAMP and ADM(22-52) did not. ADM stimulated transiently c-fos mRNA in a concentration-dependent manner. Monoclonal antibody G6, which neutralizes ADM, significantly inhibited C6 proliferation and decreased the ability of ADM to elevate c-fos mRNA. These data suggest that ADM is a regulatory peptide of C6 cells.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9396050 DOI: 10.1016/s0196-9781(97)00179-4
Source DB: PubMed Journal: Peptides ISSN: 0196-9781 Impact factor: 3.750